West Pharmaceutical Services, Inc. (WST)
Summary
West Pharmaceutical Stock Gains 36.1% YTD: What's Behind the Rally?
West Pharmaceutical Services WST shares have gained 36.1% year to date, significantly outperforming its industry's advancement of 7.8%. The rally reflects improving demand for high-value pharmaceutical packaging components, stronger-than-expected earnings, and an upward revision to full-year guidance.
West Pharma: Still A Buy, But Expectations Are Rising
West Pharmaceutical Services remains a buy despite a demanding valuation, driven by new growth catalysts and robust financial performance. Double-digit growth from GLP-1s, HVP upgrades, and the multiyear Annex 1 regulatory opportunity underpin WST's bullish outlook. Annex 1 upgrades represent a multiyear, regulatory-driven mix shift, with only ~1B of a 6B component opportunity converted so far.
Reasons to Add West Pharmaceutical Stock to Your Portfolio Now
West Pharmaceutical's biologics exposure, Annex 1 projects and delivery-device growth support prospects despite near-term headwinds.
West Pharmaceutical Services, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| TJD Thomas John Drogan PR Inc.IPAL SECURITIES Inc. | 660 | $237,077 | $252,793.2 | $15,716.2 | 6.63% |
 Timothy M. Bidwell Hazlett, BURT & WATSON Inc. | 100 | $39,571 | $38,201 | -$1,370 | -3.46% |
| LC Lisa Candera CIGNA INVESTMENTS Inc. /NEW | 671 | $240,000 | $255,785.2 | $15,785.2 | 6.58% |
 Curtis Ellergodt Rothschild Investment LLC | 93 | $24,942.91 | $34,842.45 | $9,899.54 | 39.69% |
| BZ Brandon Zatopek Commonwealth Equity Services LLC | 2,471 | $886,951 | $925,760.13 | $38,809.13 | 4.38% |
West Pharmaceutical Services, Inc. (WST) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has West Pharmaceutical Services, Inc. ever had a stock split?
West Pharmaceutical Services, Inc. Profile
| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Michel Lagarde CEO | NYSE Exchange | 955306105 CUSIP |
| US Country | 10,800 Employees | 29 Jul 2026 Last Dividend | 27 Sep 2013 Last Split | 13 Jan 1978 IPO Date |
Overview
West Pharmaceutical Services, Inc. is a leading global provider in the design, manufacturing, and sale of containment and delivery systems for injectable drugs and healthcare products. With a presence across the Americas, Europe, the Middle East, Africa, and the Asia Pacific, the company operates through two primary segments: Proprietary Products and Contract-Manufactured Products. Founded in 1923 and headquartered in Exton, Pennsylvania, West Pharmaceutical Services, Inc. is dedicated to serving biologic, generic, and pharmaceutical drug companies, as well as pharmaceutical, diagnostic, and medical device companies through a comprehensive sales force, distribution network, contract sales agents, and regional distributors.
Products and Services
- Stoppers and Seals for Injectable Packaging Systems: These are designed for use in vials and other packaging systems to ensure the integrity and sterility of injectable drugs.
- Syringe and Cartridge Components: This includes custom solutions for injectable drug applications, offering enhanced safety and efficiency in drug delivery through advanced technologies in reconstitution, mixing, and transfer.
- Films, Coatings, Washing, Vision Inspection, and Sterilization Services: These services aim to improve the quality of packaging components, ensuring that they meet stringent healthcare standards.
- Drug Containment Solutions: Among their offerings is Crystal Zenith, a high-performance cyclic olefin polymer used in formulating vials, syringes, and cartridges. This product line is geared towards providing superior containment solutions for sensitive biologics and other pharmaceuticals.
- Self-Injection Devices: These devices are designed to facilitate self-administration of drugs, improving patient compliance and convenience. West also offers a variety of integrated services such as analytical lab services, pre-approval primary packaging support, engineering development, regulatory expertise, and after-sales technical support to complement these offerings.
- Design, Manufacture, and Automated Assembly of Devices: Within their Contract-Manufactured Products segment, the focus is on creating devices for surgical, diagnostic, ophthalmic, injectable, and various drug delivery systems, as well as consumer products. This entails a close collaboration with pharmaceutical, diagnostic, and medical device companies to develop solutions that meet specific requirements.
Contact Information
